Nephrotic Syndrome Induced by Tiopronin in a Male Patient with Cystinuria
By:
References
- Servais A, Thomas K, Dello Strologo L. et al. Cystinuria: clinical practice recommendation. Kidney Int. 2021;99(1):48–58.
- Chillarón J, Font-Llitjós M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacín M. Pathophysiology and treatment of cystinuria. Nat Rev Nephrol. 2010 Jul;6(7):424–434.
- Sahota A, Tischfield JA, Goldfarb DS, Ward MD, Hu L. Cystinuria: genetic aspects, mouse models, and a new approach to therapy. Urolithiasis. 2019;47(1):57–66.
- Dello Strologo L, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, de Sanctis L, Ponzone A, Gallucci M et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol. 2002 Oct;13(10):2547–2553.
- Vidović L, Josipović J, Šenjug P. Tiopronin and/or NSAID? A case of nephrotic syndrome and acute interstitial nephritis in a young woman with cystinuria. Acta Clin Croat (Suppl 1) 2021; 60: 125–127.
- Zhong H, Wang L, Gu ZC, Cui M, Liu XY, Pang XY. Minimal change disease induced by tiopronin: a rare case report and a review of the literature. Ann Transl Med. 2019 Aug;7(16):398.
- Li XP, Wen F, Yang W, et al. The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis. Tumori 2014;100:446–451.
- Tang MC, Cheng L, Qiu L, et al. Efficacy of Tiopronin in treatment of severe non-alcoholic fatty liver disease. Eur Rev Med Pharmacol Sci 2014;18:160–164.
- Li J, Qiu X, Guo W, et al. Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma. Med Oncol 2015;32:238.
- Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, et al Adverse events associated with currently used medical treatments for cystinuria and treatment goals: Results from a series of 442 patients in France. BJU Int. 2019;124:849–861.
- Ferraccioli GF, Peri F, Nervetti A, Mercadanti M, Cavalieri F, Dall’Aglio PP, Savi M, Ferrari C. Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics. Clin Exp Rheumatol. 1986 Jan–Mar;4(1):9–15.
- Salvarani C, Macchioni P, Rossi F, et al. Nephrotic syndrome induced by tiopronin: association with the HLA-DR3 antigen. Arthritis Rheum 1985;28:595–596.
- Tryggvason K, Pettersson E et al. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure (Review). J Intern Med 2003; 254: 216–224
- Yamashita J, Hirakawa Y, Sato Y, Abe H, Akiyama S, Maruyama S, Kume H, Nangaku M. A Case of Tiopronin-induced Membranous Nephropathy Presenting with IgG4-predominant Staining Pattern. Intern Med. 2024 Sep 11. doi: 10.2169/internalmedicine.4047-24. Epub ahead of print. PMID: 39261067.
- Santoriello D, Ramaswamy R, Kudose S, Markowitz GS. Segmental NELL-1 Membranous Nephropathy Complicating Tiopronin Therapy. Kidney Int Rep. 2023 May 30;8(8):1683–1686.
- Tasic V, Lozanovski VJ, Ristoska-Bojkovska N, Sahpazova E, Gucev Z. Nephrotic syndrome occurring during tiopronin treatment for cystinuria. Eur J Pediatr. 2011 Feb;170(2):247–249.
- Rizzoni G, Pavanello L, Dussini N, Chiandetti L, Zacchello G. Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine. J Urol. 1979 Sep;122(3):381–382.
- Iwanaka, Yuma & Abe, Yoshifusa & Watanabe, Shuichiro. (2024). Tiopronin-nephropathy in a female adolescent patient with cystinuria. Japanese journal of pediatric nephrology. 2024(37): 63–67.
- Al Kalbani, Naifain; Al Maskari, Anisa; Al Saidi, Suliman; Al Ghaithi, Badria; Al Riyami, Mohammed S.. Nephrotic Syndrome in a Child with Cystinuria. Asian Journal of Pediatric Nephrology. 2020;3(2):82–83.
- S Micallef, L Delicata, J Farrugia Agius, and S Holwill British Journal of Hospital Medicine. 2022;83(8)1–4.
- Lecoules S, Duvic C, Hérody M, Nédélec G. Syndrome néphrotique à lésions glomérulaires minimes secondaire à la prise de tiopronine [Tiopronin-induced nephrotic syndrome with minimal glomerular lesions]. Presse Med. 1999 Feb 13;28(6):273–275.
- Shibasaki T, Murai S, Kodama K, Nakano H, Ishimoto F, Sakai O. A case of nephrotic syndrome due to alpha-mercaptopropionyl glycine in a patient with familial cystinuria. Nihon Jinzo Gakkai Shi. 1990 Aug;32(8):933–937.
DOI: https://doi.org/10.2478/bjmg-2025-0012 | Journal eISSN: 2199-5761
Language: English
Published on: Oct 8, 2025
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2025 V Karanfilovski, A Severova Stojanoska, V Ristovska, J Gjorgjievska, V Tasic, T Arsov, P Dzekova-Vidimliski, D Plaseska-Karanfilska, I Nikolov, N Gjorgjievski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.